- Replys to Correspondence Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
- Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
- Clin Mol Hepatol. 2024;30(4):1039-1041.
- Editorials Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis”
- Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
- Clin Mol Hepatol. 2024;30(4):649-652.
- Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
- Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
- Clin Mol Hepatol. 2021;27(1):83-86.